P2.01-120 First Study to Evaluate the Efficacy of SB Oral Solution to Prevent Neutropenia and FN Induced by Platinum-Based Chemotherapy in Lung Cancer

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1175
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P2.01-35 Predicting Risk of Chemotherapy-Induced Severe Neutropenia in Patients With Advanced Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.01-54 Predictive Factors for Thromboembolism in Advanced Lung Cancer Patients on Platinum Chemotherapy: A Prospective Study

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Expanded Access to Pembrolizumab From Cost-Savings Generated by Biosimilar Filgrastim (BIOSIM-FIL) in the Prophylaxis of Chemotherapy-Induced (FEBRILE) Neutropenia (CIN/FN): Simulation Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Rechallenge With First-Line Platinum Chemotherapy for Sensitive-Relapsed Small-Cell Lung Cancer

Case Reports in Oncology
Oncology
2018English

Genetic Polymorphisms and Platinum-Based Chemotherapy-Induced Toxicities in Patients With Lung Cancer: A Systematic Review and Meta-Analysis

Frontiers in Oncology
Cancer ResearchOncology
2020English

Multicenter Randomized, Double-Blind Controlled Trial to Evaluate the Efficacy of Laser Therapy for the Treatment of Severe Oral Mucositis Induced by Chemotherapy in Children: laMPO RCT

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2018English

P2.01-55 Dual-Energy CT Scan to Evaluate Sarcopenia in Lung Cancer in Comparison With Conventional CT Scan

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Timing of Chemotherapy-Induced Neutropenia: The Prognostic Factor in Advanced Pancreatic Cancer Patients Treated With Gemcitabine / Gemcitabine-Based Chemotherapy

Oncotarget
Oncology
2017English

Cost-Utility of Granulocyte-Colony Stimulating Factors (G-CSFs) for Primary Prophylaxis (PP) of Chemotherapy Induced Febrile Neutropenia (FN) in Breast Cancer Patients in the Netherlands

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy